We are all unique. Our health is determined by our genome combined with our lifestyles and environment. By joining information about our genome with other clinical and diagnostic information, patterns can be identified and help to determine our individual risk of developing disease, detect illness earlier and determine the most effective interventions to improve our health.

Personalized medicine is making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease and in many cases refining an individual’s clinical care.

In this meeting we bring together scientists in the field who have developed their research in collaboration with the CNAG-CRG and who will present their latest research discoveries and ideas on the topic.

AGENDA

Speakers

Silvia Beà, Lymphoid Program, Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS)

Sergi Beltran, Head, Bioinformatics Analysis Unit, Centro Nacional de Análisis Genómico (CNAG-CRG)

Gabriel Capellá, Director, IDIBELL; Director Hereditary Cancer Program, Institut Català d'Oncologia (IDIBELL-ICO)

Ángel Carracedo, Galician Foundation of Genomic Medicine (SERGAS), Genomic Medicine Group, University of Santiago de Compostela (USC)

Roser González, Professor in Genetics, DBGen Founder, University of Barcelona (UB)

Dennis Horgan, Executive Director, European Alliance for Personalised Medicine (EUAPM)

Jimmy Jin, Global Marketing Director, NGS, Agilent

Alfons Macaya, Head, Pediatric Neurology Section, Vall d'Hebron Research Institute (VHIR)

Miguel Ángel Piris, As. Medical Chief, Pathology Service, Fundación Jiménez Díaz (FJD)

Ana Vivancos, Cancer Genomics Group, Vall d’Hebron Institute of Oncology (VHIO)

Sponsored by:

Agilent_Logo_Tag_v_RGB.png

Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.